Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1373/clinchem.2018.292136 | DOI Listing |
Scand J Immunol
January 2024
Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Sci Rep
May 2022
Bevital AS, Jonas Lies veg 87, 5021, Bergen, Norway.
Protein biomarkers and microheterogeneity have attracted increasing attention in epidemiological and clinical research. Knowledge of within-person reproducibility over time is paramount to determine whether a single measurement accurately reflects an individual's long-term exposure. Yet, research investigating within-person reproducibility for proteoforms is limited.
View Article and Find Full Text PDFTalanta
February 2021
Bevital AS, Jonas Lies veg 87, Laboratory building, 5021, Bergen, Norway.
Protein biomarker microheterogeneity has attracted increasing attention in epidemiological and clinical research studies. Knowledge concerning the preanalytical stability of proteins is paramount to assess the biological significance of their proteoforms. We investigated the stability of the inflammatory markers C-reactive protein (CRP), serum amyloid A (SAA), and calprotectin (S100A8/9), and the renal function marker, cystatin C (CnC).
View Article and Find Full Text PDFClin Chem
September 2018
Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada;
Anal Chem
March 2018
Department of Clinical Science , University of Bergen, 5021 Bergen , Norway.
Circulating proteins are widely used as biomarkers in clinical applications for the diagnosis, prediction, and treatment of numerous diseases. Immunoassays are the most common technologies for quantification of protein biomarkers and exist in various formats. Traditional immunoassays offer sensitive and fast analyses but cannot differentiate between proteoforms.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!